API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
0
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.globenewswire.com//news-release/2023/11/13/2779021/23024/en/Intercept-Announces-New-Phase-2-Data-Showing-Significant-Impact-of-OCA-Bezafibrate-Combination-on-Normalization-of-Multiple-Key-Biomarkers-of-PBC-Induced-Liver-Damage-at-AASLD-The-.html
https://www.globenewswire.com/news-release/2023/06/23/2693415/23024/en/Intercept-Presents-New-Data-Showing-Significant-Impact-of-OCA-bezafibrate-Combination-on-Normalization-of-Multiple-Biomarkers-of-PBC-Induced-Liver-Damage.html
https://www.globenewswire.com/news-release/2023/06/07/2683624/23024/en/Intercept-Announces-New-Data-Showing-Potential-of-Fixed-Dose-Combination-of-OCA-and-Bezafibrate-to-Normalize-Multiple-Biomarkers-in-PBC-to-be-Featured-in-Podium-Presentation-at-EAS.html
https://www.globenewswire.com/news-release/2022/05/11/2440783/23024/en/Intercept-Announces-First-Patient-Dosed-in-Phase-2-Study-of-OCA-and-Bezafibrate-for-the-Treatment-of-Primary-Biliary-Cholangitis.html
https://www.clinicaltrialsarena.com/comment/intercepts-phase-ii-ready-ocaliva-bezafibrate-has-mixed-experts-views-in-primary-biliary-cholangitis/
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/anvisa+suspende+empresa+sinbiotik+por+irregularidades